Evidence map›Paper›PMID 36624371›Full record

Trial reportBMC anesthesiology2023

Comparison of hemodynamics during induction of general anesthesia with remimazolam and target-controlled propofol in middle-aged and elderly patients: a single-center, randomized, controlled trial.

Ryo Sekiguchi, Michiko Kinoshita, Ryosuke Kawanishi, Nami Kakuta, Yoko Sakai, Katsuya Tanaka

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC anesthesiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ryo SekiguchiDepartment of Anesthesiology, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan. rsekiguchi17@gmail.com.
Michiko KinoshitaDepartment of Anesthesiology, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan.
Ryosuke KawanishiSurgical Center, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan.
Nami KakutaDepartment of Anesthesiology, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan.
Yoko SakaiDivision of Anesthesiology, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan.
Katsuya TanakaDepartment of Anesthesiology, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8503, Japan.
Tokushima University Hospital · JP

Funding

Japan Society for the Promotion of Science 19K09352Japan Society for the Promotion of Science 20K17814
6 · The paper itself

Abstract

backgroundRemimazolam confers a lower risk of hypotension than propofol. However, no studies have compared the efficacy of remimazolam and propofol administered using target-controlled infusion (TCI). This study aimed to investigate hemodynamic effects of remimazolam and target-controlled propofol in middle-aged and elderly patients during the induction of anesthesia.

methodsForty adults aged 45-80 years with the American Society of Anesthesiologists Physical Status 1-2 were randomly assigned to remimazolam or propofol group (n = 20 each). Patients received either remimazolam (12 mg/kg/h) or propofol (3 μg/mL, TCI), along with remifentanil for inducing anesthesia. We recorded the blood pressure, heart rate (HR), and estimated continuous cardiac output (esCCO) using the pulse wave transit time. The primary outcome was the maximum change in mean arterial pressure (MAP) after induction. Secondary outcomes included changes in HR, cardiac output (CO), and stroke volume (SV).

resultsMAP decreased after induction of anesthesia in both groups, without significant differences between the groups (- 41.1 [16.4] mmHg and - 42.8 [10.8] mmHg in remimazolam and propofol groups, respectively; mean difference: 1.7 [95% confidence interval: - 8.2 to 4.9]; p = 0.613). Furthermore, HR, CO, and SV decreased after induction in both groups, without significant differences between the groups. Remimazolam group had significantly shorter time until loss of consciousness than propofol group (1.7 [0.7] min and 3.5 [1.7] min, respectively; p < 0.001). However, MAP, HR, CO, and SV were not significantly different between the groups despite adjusting time until loss of consciousness as a covariate. Seven (35%) and 11 (55%) patients in the remimazolam and propofol groups, respectively, experienced hypotension (MAP < 65 mmHg over 2.5 min), without significant differences between the groups (p = 0.341).

conclusionsHemodynamics were not significantly different between remimazolam and target-controlled propofol groups during induction of anesthesia. Thus, not only the choice but also the dose and usage of anesthetics are important for hemodynamic stability while inducing anesthesia. Clinicians should monitor hypotension while inducing anesthesia with remimazolam as well as propofol.

trial registrationUMIN-CTR (UMIN000045612).

Indexed as

HypotensionPropofolAdultAgedAnesthesia, GeneralAnesthetics, IntravenousBenzodiazepinesHemodynamicsHumansMiddle AgedPiperidinesUnconsciousnessAnesthetics, IntravenousBenzodiazepinesPiperidinesPropofolremimazolamHemodynamicsHypotensionPropofolRemimazolamTarget-controlled infusion

Identifiers

PMID36624371
PMCPMC9830695
OpenAlexW4313885829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.